Thread by @Farrier105

@YoureAllDunces Something else has to be broached as we confront the addition of this claimed safety feature for the vaccine spike protein that is supposed to prevent binding to ACE2 receptors.

The creation of the safety feature would further change the RNA genome of the vaccine's spike protein from the genome of the virus' spike protein. I don't think this fact is remotely debatable, but desperation can result in just about anything.

These differences in the appearances, and the genetic structures between the spike protein of the vaccine and the spike protein of the virus inspire questions about the nature of what constitutes a VARIANT of a virus.

I asked this question in an earlier thread on July 6th, and asking it again:

Is it wise to encode in mRNA a spike protein that is TOO RADICALLY UNLIKE THE WILD SPIKE PROTEIN OF THE VIRUS? Is there not a danger that coding for a spike protein that is stiff while the...

spike protein of the virus is floppy; and the vaccine spike protein can't bind with the ACE2 receptor while the spike protein of the virus does not possess such coding in its genome? Does this kind of mRNA coding just create a VARIANT spike protein like that of the DELTA...

Variant, against which the vaccines do not provide immunity? For what is the recipient of the vaccine given immunity, for the actual spike protein of the virus, or just immunity for the SPIKE PROTEIN OF THE VACCINE?

Legitimate question in my opinion.

@threadreaderapp Unroll for future use, please.